| |
| |
|
| Insider
Information: |
Ramaswamy Vivek |
| Relationship: |
10% Owner |
| City: |
Burnaby |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
53,486,341 |
|
|
Indirect Shares
|
91,013,540 |
|
|
| Direct
Value |
$582,552,461 |
|
|
|
Indirect Value
|
$79,566,964 |
|
|
| Total
Shares |
144,499,881 |
|
|
| Total
Value |
$662,119,426 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 5.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tekmira Pharmaceuticals Corp |
TKMR |
Director, 10% Owner |
2015-03-04 |
54,915 |
2015-03-04 |
16,013,540 |
Premium* |
|
|
Sio Gene Therapies Inc |
SIOX |
Officer, Director, 10%... |
|
0 |
2015-06-10 |
75,000,000 |
Premium* |
|
|
Roivant Sciences Ltd. |
ROIV |
10% Owner |
2024-04-02 |
53,431,426 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ROIV |
Roivant Sciences Ltd. |
10% Owner |
– – • |
2024-04-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
53,431,426 |
|
% |
|
| ROIV |
Roivant Sciences Ltd. |
10% Owner |
– – • |
2024-01-02 |
4 |
S |
$11.05 |
$33,150,000 |
D/D |
(3,000,000) |
51,929,426 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • • |
2023-12-27 |
4 |
D |
$11.58 |
$1,550,689 |
D/D |
(133,911) |
54,929,426 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • • |
2023-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
275,227 |
55,063,337 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • • |
2023-09-28 |
4 |
D |
$12.67 |
$784,868 |
D/D |
(61,947) |
54,788,110 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • • |
2023-09-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
119,534 |
54,850,057 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • • |
2023-08-28 |
4 |
D |
$11.25 |
$536,535 |
D/D |
(47,692) |
54,730,523 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • • |
2023-08-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
86,714 |
54,778,215 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • • |
2023-07-31 |
4 |
D |
$11.43 |
$868,943 |
D/D |
(76,023) |
54,691,501 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • • |
2023-07-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
166,057 |
54,767,524 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • • |
2023-05-31 |
4 |
D |
$9.09 |
$1,726,618 |
D/D |
(189,947) |
54,601,467 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • • |
2023-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
382,203 |
54,791,414 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2023-02-22 |
4 |
S |
$7.95 |
$31,800,000 |
D/D |
(4,000,000) |
54,409,211 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
Director |
– • – |
2021-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
58,409,211 |
|
- |
|
| SIOX |
Sio Gene Therapies Inc |
Principal Executive OfficerOff |
• • • |
2015-06-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
75,000,000 |
|
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Director |
– • • |
2015-03-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
16,013,540 |
|
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Director |
– • • |
2015-03-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
54,915 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
